The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal

Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

RFK Jr.'s Vaccine Panel Set to Ignite New Debate on COVID-19 Shot Guidance

Lilly's Groundbreaking Weight-Loss Pill Shows Promising Early Results, But The Journey Continues

The Unseen Fallout: How Washington's Anti-Vaccine Stance Cripples a Vital Industry

The Hidden Cost of Commercials: How Deceptive Drug Ads Are Eroding Patient Trust

RFK Jr.'s Congressional Testimony Ignites Firestorm of Vaccine Misinformation Concerns

The Perilous Addiction: How UK Businesses Are Getting Hooked on Rebates and Why It Matters